About
Octagon Therapeutics develops medicines aimed at treating autoimmune and inflammatory diseases by restoring disrupted immune checkpoint receptors to maintain healthy immune function.
Explore Octagon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.